Psyence Biomedical Ltd.
PBM
$0.5171
-$0.0162-3.04%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 105.97% | -0.08% | -2,983.07% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 800.00% | 0.00% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -109.44% | 0.00% | 140,519.89% | 0.00% |
| Change in Net Operating Assets | 0.00% | 115.19% | 0.10% | -2,395.88% | 0.00% |
| Cash from Operations | 0.00% | -11.08% | -3.02% | 16.60% | 0.00% |
| Capital Expenditure | 0.00% | -10.34% | 0.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -10.34% | 0.00% | -- | -- |
| Total Debt Issued | 0.00% | -44.18% | 1.01% | 148.03% | 0.00% |
| Total Debt Repaid | -- | -- | 0.00% | -- | -- |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 2.45% | -201.66% | 0.00% |
| Cash from Financing | 0.00% | 81.66% | 1.46% | 71.82% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 837.03% | -12.57% | 120.09% | 0.00% |